Labmate (Asia) Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 3.24 M
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
- Revenue Growth 10.97%
- Profit Growth -35.58%
- Ebitda -37.79%
- Net Worth 23.81%
- Total Assets 8.47%
About Labmate (Asia)
Labmate (Asia) Private Limited (LAPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 July 1992 and has a history of 32 years and six months. Its registered office is in Chennai 600 015, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 3.24 M.
The company currently has active open charges totaling ₹1.50 Cr.
Jagannathan Thiagarajan, Nirmala Viswanathan, and Viswanathan Subramanian serve as directors at the Company.
Company Details
- Location
Chennai 600 015, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U33112TN1992PTC023173
- Company No.
023173
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 1992
- Date of AGM
16 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Labmate (Asia) Private Limited offer?
Labmate (Asia) Private Limited offers a wide range of products and services, including Biofuel, Biomass, Medical Laboratory Instruments, Blood Bank Equipments.
Who are the key members and board of directors at Labmate (Asia)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viswanathan Subramanian  | Whole-Time Director | 29-Jul-1992 | Current |
| Jagannathan Thiagarajan | Director | 11-Jul-2011 | Current |
| Nirmala Viswanathan | Director | 10-Dec-2010 | Current |
Financial Performance of Labmate (Asia).
Labmate (Asia) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.97% increase. The company also saw a substantial fall in profitability, with a 35.58% decrease in profit. The company's net worth Soared by an impressive increase of 23.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labmate (Asia)?
In 2023, Labmate (Asia) had a promoter holding of 61.87% and a public holding of 38.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2001 | Uco Bank | ₹1.50 Cr | Open |
How Many Employees Work at Labmate (Asia)?
Labmate (Asia) has a workforce of 50 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labmate (Asia), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labmate (Asia)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
